|
1
|
Bush DA, Smith JC, Slater JD, Volk ML,
Reeves ME, Cheng J, Grove R and de Vera ME: Randomized clinical
trial comparing proton beam radiation therapy with transarterial
chemoembolization for hepatocellular carcinoma: Results of an
interim analysis. Int J Radiat Oncol Biol Phys. 95:477–482. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma M, Tuaine J, McLaren B, Waters DL,
Black K, Jones LM and McCormick SP: Chemotherapy agents alter
plasma lipids in breast cancer patients and show differential
effects on lipid metabolism genes in liver cells. PLoS One.
11:e01480492016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo JR, Shen HC, Liu Y, Xu F, Zhang YW,
Shao Y and Su YJ: Effect of acute normovolemic hemodilution
combined with controlled low central venous pressure on blood
coagulation function and blood loss in patients undergoing
resection of liver cancer operation. Hepatogastroenterology.
62:992–996. 2015.PubMed/NCBI
|
|
4
|
Han S, Tang Q, Lu X, Chen R, Li Y, Shu J,
Zhang X and Cao J: Dysregulation of hepatic microRNA expression
profiles with Clonorchis sinensis infection. BMC Infect Dis.
16:7242016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He S, Zhang DC and Wei C: MicroRNAs as
biomarkers for hepatocellular carcinoma diagnosis and prognosis.
Clin Res Hepatol Gastroenterol. 39:426–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan Y, Lin B, Ye Y, Wen D, Chen L and Zhou
X: Differential expression of serum microRNAs in cirrhosis that
evolve into hepatocellular carcinoma related to hepatitis B virus.
Oncol Rep. 33:2863–2870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng X, Jiang J, Shi S, Xie H, Zhou L and
Zheng S: Knockdown of miR-25 increases the sensitivity of liver
cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad
signaling pathway. Int J Oncol. 49:2600–2610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sui Y, Zheng X and Zhao D: Rab31 promoted
hepatocellular carcinoma (HCC) progression via inhibition of cell
apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway. Tumour Biol.
36:8661–8670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Palian BM, Rohira AD, Johnson SA, He L,
Zheng N, Dubeau L, Stiles BL and Johnson DL: Maf1 is a novel target
of PTEN and PI3K signaling that negatively regulates oncogenesis
and lipid metabolism. PLoS Genet. 10:e10047892014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang H, Zhao B, Huang C, Meng XM, Bian EB
and Li J: Melittin restores PTEN expression by down-regulating
HDAC2 in human hepatocelluar carcinoma HepG2 cells. PLoS One.
9:e955202014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shin SY, Kim CG, Jung YJ, Lim Y and Lee
YH: The UPR inducer DPP23 inhibits the metastatic potential of
MDA-MB-231 human breast cancer cells by targeting the
Akt-IKK-NF-κB-MMP-9 axis. Sci Rep. 6:341342016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manna K, Khan A, Das Kr D, Kesh Bandhu S,
Das U, Ghosh S, Dey Sharma R, Saha Das K, Chakraborty A,
Chattopadhyay S, et al: Protective effect of coconut water
concentrate and its active component shikimic acid against
hydroperoxide mediated oxidative stress through suppression of
NF-κB and activation of Nrf2 pathway. J Ethnopharmacol.
155:132–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moulton CA, Gu CS, Law CH, Tandan VR, Hart
R, Quan D, Smith Fairfull RJ, Jalink DW, Husien M, Serrano PE, et
al: Effect of PET before liver resection on surgical management for
colorectal adenocarcinoma metastases: A randomized clinical trial.
JAMA. 311:1863–1869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Melucci E, Cosimelli M, Carpanese L, Pizzi
G, Izzo F, Fiore F, Golfieri R, Giampalma E, Sperduti I, Ercolani
C, et al: Italian Society of Locoregional Therapies in Oncology
(S.I.T.I.L.O.): Decrease of survivin, p53 and Bcl-2 expression in
chemorefractory colorectal liver metastases may be predictive of
radiosensivity radiosensivity after radioembolization with
yttrium-90 resin microspheres. J Exp Clin Cancer Res. 32:132013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gnoni A, Santini D, Scartozzi M, Russo A,
Licchetta A, Palmieri V, Lupo L, Faloppi L, Palasciano G, Memeo V,
et al: Hepatocellular carcinoma treatment over sorafenib:
Epigenetics, microRNAs and microenvironment. Is there a light at
the end of the tunnel? Expert Opin Ther Targets. 19:1623–1635.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun J, Zhou M, Yang H, Deng J, Wang L and
Wang Q: Inferring potential microRNA-microRNA associations based on
targeting propensity and connectivity in the context of protein
interaction network. PLoS One. 8:e697192013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He J, Zhao K, Zheng L, Xu Z, Gong W, Chen
S, Shen X, Huang G, Gao M, Zeng Y, et al: Upregulation of
microRNA-122 by farnesoid X receptor suppresses the growth of
hepatocellular carcinoma cells. Mol Cancer. 14:1632015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park KU, Seo YS, Lee YH, Park J, Hwang I,
Kang KJ, Nam J, Kim SW and Kim JY: Altered microRNA expression
profile in hepatitis B virus-related hepatocellular carcinoma.
Gene. 573:278–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W, et al: MiR-20a induces
cell radioresistance by activating the PTEN/PI3K/Akt
signaling pathway in hepatocellular carcinoma. Int J Radiat Oncol
Biol Phys. 92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu A, Kang N, He L, Li X, Xu X and Zhang
H: miR-221 and miR-26b regulate chemotactic migration of MSCs
toward HGF through activation of Akt and FAK. J Cell Biochem.
117:1370–1383. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo J, Zhou H, Wang F, Xia X, Sun Q, Wang
R and Cheng B: The hepatitis B virus X protein downregulates NF-κB
signaling pathways through decreasing the Notch signaling pathway
in HBx-transformed L02 cells. Int J Oncol. 42:1636–1643. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsieh SC, Tsai JP, Yang SF, Tang MJ and
Hsieh YH: Metformin inhibits the invasion of human hepatocellular
carcinoma cells and enhances the chemosensitivity to sorafenib
through a downregulation of the ERK/JNK-mediated NF-κB-dependent
pathway that reduces uPA and MMP-9 expression. Amino Acids.
46:2809–2822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alidzanovic L, Starlinger P, Schauer D,
Maier T, Feldman A, Buchberger E, Stift J, Koeck U, Pop L,
Gruenberger B, et al: The VEGF rise in blood of bevacizumab
patients is not based on tumor escape but a host-blockade of VEGF
clearance. Oncotarget. 7:57197–57212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo LY, Zhu P and Jin XP: Association
between the expression of HIF-1α and VEGF and prognostic
implications in primary liver cancer. Genet Mol Res. 15:152016.
View Article : Google Scholar
|
|
25
|
Zheng CG, Chen R, Xie JB, Liu CB, Jin Z
and Jin C: Immunohistochemical expression of Notch1, Jagged1, NF-κB
and MMP-9 in colorectal cancer patients and the relationship to
clinicopathological parameters. Cancer Biomark. 15:889–897. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grünwald B, Vandooren J, Locatelli E,
Fiten P, Opdenakker G, Proost P, Krüger A, Lellouche JP, Israel LL,
Shenkman L, et al: Matrix metalloproteinase-9 (MMP-9) as an
activator of nanosystems for targeted drug delivery in pancreatic
cancer. J Control Release. 239:39–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li D, Wei Y, Wang D, Gao H and Liu K:
MicroRNA-26b suppresses the metastasis of non-small cell lung
cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways. Biochem
Biophys Res Commun. 472:465–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
